Variant report
Variant | esv1833145 |
---|---|
Chromosome Location | chr4:60293703-60330880 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113059653 | chr4:60300603-60300604 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs553649042 | chr4:60300609-60300610 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182422124 | chr4:60300741-60300742 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187031175 | chr4:60300763-60300764 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560738007 | chr4:60300785-60300786 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576062196 | chr4:60300896-60300897 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139548604 | chr4:60300929-60300930 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191956571 | chr4:60300941-60300942 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368287157 | chr4:60300948-60300949 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181460428 | chr4:60300956-60300957 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs111310937 | chr4:60300960-60300961 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563284901 | chr4:60300969-60300970 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185606274 | chr4:60300977-60300978 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149696485 | chr4:60300987-60300988 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190063124 | chr4:60300989-60300990 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73194576 | chr4:60300996-60300997 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs192967566 | chr4:60315000-60315001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs6820858 | chr4:60315007-60315008 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs531591537 | chr4:60315010-60315011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556381292 | chr4:60315026-60315027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73196606 | chr4:60315069-60315070 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs377101766 | chr4:60315070-60315071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532471426 | chr4:60315081-60315082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79277808 | chr4:60315114-60315115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551117227 | chr4:60315117-60315118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6827039 | chr4:60315125-60315126 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs141210806 | chr4:60315171-60315172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75691326 | chr4:60315214-60315215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558880044 | chr4:60315242-60315243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548986344 | chr4:60315246-60315247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77808496 | chr4:60315247-60315248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577202787 | chr4:60315256-60315257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182993938 | chr4:60315273-60315274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556148725 | chr4:60315296-60315297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543996746 | chr4:60315306-60315307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs137931626 | chr4:60315327-60315328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs377666841 | chr4:60315351-60315352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538747447 | chr4:60315352-60315353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6827654 | chr4:60315365-60315366 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs376463832 | chr4:60315384-60315385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572673816 | chr4:60315412-60315413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147135484 | chr4:60315473-60315474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs1567566 | chr4:60315492-60315493 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs1018263 | chr4:60315535-60315536 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs576695237 | chr4:60315542-60315543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543405010 | chr4:60315591-60315592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368021294 | chr4:60315596-60315597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187335331 | chr4:60315611-60315612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532409135 | chr4:60315649-60315650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs547480859 | chr4:60315650-60315651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 20369283 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:60300600-60301000 | Active TSS | A549 | lung |
2 | chr4:60315000-60315600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr4:60315400-60315600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr4:60315600-60317800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr4:60317800-60318000 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr4:60318000-60323000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr4:60323000-60323400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr4:60323000-60323800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr4:60323000-60323800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr4:60323200-60323400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr4:60323200-60323600 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr4:60323200-60323600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr4:60323200-60323600 | Enhancers | HUES64 Cell Line | embryonic stem cell |